naratriptan and ly 334370

naratriptan has been researched along with ly 334370 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audia, JE; Krushinski, JH; Lucaites, VL; Nelson, DL; Schaus, JM; Wainscott, DB; Zgombick, JM1
Adham, N; Audia, JE; Branchek, TA; Cohen, ML; Durkin, MM; Flaugh, ME; Johnson, KW; Kaldor, SW; Phebus, LA; Schaus, JM; Zgombick, JM1

Other Studies

2 other study(ies) available for naratriptan and ly 334370

ArticleYear
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:3

    Topics: Animals; Benzamides; Brain; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Ligands; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Transfection; Tritium

2005
5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs.
    Neuroreport, 1997, Jul-07, Volume: 8, Issue:9-10

    Topics: Animals; Benzamides; Carbazoles; Disease Models, Animal; Guinea Pigs; In Situ Hybridization; Indoles; Inflammation; Male; Piperidines; Pyrazoles; Rabbits; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; RNA, Messenger; Serotonin Receptor Agonists; Trigeminal Ganglion; Tryptamines

1997